Ray Cody Mayo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ray Cody Mayo has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Jessica W. T. Leung
Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030-4009
3 shared publicationsJay R. Parikh
Department of Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, CPB 5.3208, Houston, TX, USA
2 shared publicationsJessica Leung
The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1350, Houston, TX 77030, United States
2 shared publicationsJessica W.T. Leung
Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
2 shared publicationsAlyssa T. Watanabe
Voxel Imaging, Inc., 2711 N. Sepulveda Blvd., #284, Manhattan Beach, CA, 90266, USA
1 shared publication- Alyssa T. Watanabe
Department of Radiology, University of Southern California Keck School of Medicine , Los Angeles, CA
1 shared publication
Latest Publications
- 22 June 2026
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 23 (9) , 1851-1855
Supply Chain Vulnerabilities in Breast Imaging: Site- and Network-Level Strategies for a Concentrated Consumable Market
- 22 June 2026
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 23 (9) , 1851-1855
Supply Chain Vulnerabilities in Breast Imaging: Site- and Network-Level Strategies for a Concentrated Consumable Market
- 8 September 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 7 (1) , 45-53
Potential Impact of an Artificial Intelligence–based Mammography Triage Algorithm on Performance and Workload in a Population-based Screening Sample
To evaluate potential screening mammography performance and workload impact using a commercial artificial intelligence (AI)–based triage device in a population-based screening sample. In this retrospective study, a sample of 2129 women who underwent screening mammograms were evaluated. The performance of a commercial AI-based triage device was compared with radiologists’ reports, actual outcomes, and national benchmarks using commonly used mammography metrics. Up to 5 years of follow-up examination results were evaluated in cases to establish benignity. The algorithm sorted cases into groups of “suspicious” and “low suspicion.” A theoretical workload reduction was calculated by subtracting cases triaged as “low suspicion” from the sample. At the default 93% sensitivity setting, there was significant improvement (P <.05) in the following triage simulation mean performance measures compared with actual outcome: 45.5% improvement in recall rate (13.4% to 7.3%; 95% CI, 6.2-8.3), 119% improvement in positive predictive value (PPV) 1 (5.3% to 11.6%; 95% CI, 9.96-13.4), 28.5% improvement in PPV2 (24.6% to 31.6%; 95% CI, 24.8-39.1), 20% improvement in sensitivity (83.3% to 100%; 95% CI, 100-100), and 7.2% improvement in specificity (87.2% to 93.5%; 95% CI, 92.4-94.5). A theoretical 62.5% workload reduction was possible. At the ultrahigh 99% sensitivity setting, a theoretical 27% workload reduction was possible. No cancers were missed by the algorithm at either sensitivity. Artificial intelligence–based triage in this simulation demonstrated potential for significant improvement in mammography performance and predicted substantial theoretical workload reduction without any missed cancers.
- 8 September 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 7 (1) , 45-53
Potential Impact of an Artificial Intelligence–based Mammography Triage Algorithm on Performance and Workload in a Population-based Screening Sample
To evaluate potential screening mammography performance and workload impact using a commercial artificial intelligence (AI)–based triage device in a population-based screening sample. In this retrospective study, a sample of 2129 women who underwent screening mammograms were evaluated. The performance of a commercial AI-based triage device was compared with radiologists’ reports, actual outcomes, and national benchmarks using commonly used mammography metrics. Up to 5 years of follow-up examination results were evaluated in cases to establish benignity. The algorithm sorted cases into groups of “suspicious” and “low suspicion.” A theoretical workload reduction was calculated by subtracting cases triaged as “low suspicion” from the sample. At the default 93% sensitivity setting, there was significant improvement (P <.05) in the following triage simulation mean performance measures compared with actual outcome: 45.5% improvement in recall rate (13.4% to 7.3%; 95% CI, 6.2-8.3), 119% improvement in positive predictive value (PPV) 1 (5.3% to 11.6%; 95% CI, 9.96-13.4), 28.5% improvement in PPV2 (24.6% to 31.6%; 95% CI, 24.8-39.1), 20% improvement in sensitivity (83.3% to 100%; 95% CI, 100-100), and 7.2% improvement in specificity (87.2% to 93.5%; 95% CI, 92.4-94.5). A theoretical 62.5% workload reduction was possible. At the ultrahigh 99% sensitivity setting, a theoretical 27% workload reduction was possible. No cancers were missed by the algorithm at either sensitivity. Artificial intelligence–based triage in this simulation demonstrated potential for significant improvement in mammography performance and predicted substantial theoretical workload reduction without any missed cancers.
- Open Access
- 23 December 2023
- Published by Wiley in The Breast Journal
- Vol. 2023, 1-7
Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery
Introduction. Elucent Medical has introduced a novel EnVisio Surgical Navigation system which uses SmartClips that generate a unique electromagnetic signal triangulated in 3 dimensions for real-time navigation. The purpose of this study was to evaluate the efficacy and feasibility of the EnVisio Surgical Navigation system in localizing and excising nonpalpable lesions in breast and axillary surgery. Methods. This pilot study prospectively examined patients undergoing breast and nodal localization using the EnVisio Surgical Navigation system. SmartClips were placed by designated radiologists using ultrasound (US) or mammographic (MMG) guidance. The technical evaluation focused on successful deployment and subsequent excision of all localized lesions including SmartClips and biopsy clips. Results. Eleven patients underwent localization using 27 SmartClips which included bracketed multifocal disease (n=4) and clipped lymph node (n=1). The bracketed cases were each localized with 2 SmartClips. Mammography and ultrasound were used (n=8 and n=19, respectively) to place the SmartClips. All 27 devices were successfully deployed within 5 mm of the targeted lesion or biopsy clip. All SmartClip devices were identified and retrieved intraoperatively. No patients required a second operation for margin excision. Conclusion. In a limited sample, the EnVisio Surgical Navigation system was a reliable technology for the localization of breast and axillary lesions planned for surgical excision. Further comparative studies are required to evaluate its efficacy in relation to the other existing localization modalities.
- 23 December 2023
- Published by Wiley in The Breast Journal
- Vol. 2023, 1-7
Open AccessEvaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery
Introduction. Elucent Medical has introduced a novel EnVisio Surgical Navigation system which uses SmartClips that generate a unique electromagnetic signal triangulated in 3 dimensions for real-time navigation. The purpose of this study was to evaluate the efficacy and feasibility of the EnVisio Surgical Navigation system in localizing and excising nonpalpable lesions in breast and axillary surgery. Methods. This pilot study prospectively examined patients undergoing breast and nodal localization using the EnVisio Surgical Navigation system. SmartClips were placed by designated radiologists using ultrasound (US) or mammographic (MMG) guidance. The technical evaluation focused on successful deployment and subsequent excision of all localized lesions including SmartClips and biopsy clips. Results. Eleven patients underwent localization using 27 SmartClips which included bracketed multifocal disease (n=4) and clipped lymph node (n=1). The bracketed cases were each localized with 2 SmartClips. Mammography and ultrasound were used (n=8 and n=19, respectively) to place the SmartClips. All 27 devices were successfully deployed within 5 mm of the targeted lesion or biopsy clip. All SmartClip devices were identified and retrieved intraoperatively. No patients required a second operation for margin excision. Conclusion. In a limited sample, the EnVisio Surgical Navigation system was a reliable technology for the localization of breast and axillary lesions planned for surgical excision. Further comparative studies are required to evaluate its efficacy in relation to the other existing localization modalities.
- 1 January 2020
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 17 (1) , 175-177
Financing Artificial Intelligence in Medical Imaging: Show Me the Money
- 1 January 2020
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 17 (1) , 175-177
Financing Artificial Intelligence in Medical Imaging: Show Me the Money
- 1 July 2019
- Published by Elsevier in Clinical Imaging
- Vol. 56, 1-8
Preoperative localization of breast lesions: Current techniques
- 1 July 2019
- Published by Elsevier in Clinical Imaging
- Vol. 56, 1-8
Preoperative localization of breast lesions: Current techniques
- 1 May 2019
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 212 (5) , 1172-1173
Impact of Artificial Intelligence on Women's Imaging: Cost-Benefit Analysis
OBJECTIVE. The purpose of this article is to identify and discuss four areas in which artificial intelligence (AI) must excel to become clinically viable: performance, time, work flow, and cost. CONCLUSION. AI holds tremendous potential for transforming the practice of radiology, but certain metrics are needed to objectively quantify its impact. As patients, physicians, hospitals, and insurance companies look for value, AI must earn a role in medical imaging.
- 1 May 2019
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 212 (5) , 1172-1173
Impact of Artificial Intelligence on Women's Imaging: Cost-Benefit Analysis
OBJECTIVE. The purpose of this article is to identify and discuss four areas in which artificial intelligence (AI) must excel to become clinically viable: performance, time, work flow, and cost. CONCLUSION. AI holds tremendous potential for transforming the practice of radiology, but certain metrics are needed to objectively quantify its impact. As patients, physicians, hospitals, and insurance companies look for value, AI must earn a role in medical imaging.
- Open Access
- 8 April 2019
- Published by Springer Nature in Journal of Digital Imaging
- Vol. 32 (4) , 618-624
Reduction of False-Positive Markings on Mammograms: a Retrospective Comparison Study Using an Artificial Intelligence-Based CAD
The aim was to determine whether an artificial intelligence (AI)-based, computer-aided detection (CAD) software can be used to reduce false positive per image (FPPI) on mammograms as compared to an FDA-approved conventional CAD. A retrospective study was performed on a set of 250 full-field digital mammograms between January 1, 2013, and March 31, 2013, and the number of marked regions of interest of two different systems was compared for sensitivity and specificity in cancer detection. The count of false-positive marks per image (FPPI) of the two systems was also evaluated as well as the number of cases that were completely mark-free. All results showed statistically significant reductions in false marks with the use of AI-CAD vs CAD (confidence interval = 95%) with no reduction in sensitivity. There is an overall 69% reduction in FPPI using the AI-based CAD as compared to CAD, consisting of 83% reduction in FPPI for calcifications and 56% reduction for masses. Almost half (48%) of cases showed no AI-CAD markings while only 17% show no conventional CAD marks. There was a significant reduction in FPPI with AI-CAD as compared to CAD for both masses and calcifications at all tissue densities. A 69% decrease in FPPI could result in a 17% decrease in radiologist reading time per case based on prior literature of CAD reading times. Additionally, decreasing false-positive recalls in screening mammography has many direct social and economic benefits.
- 8 April 2019
- Published by Springer Nature in Journal of Digital Imaging
- Vol. 32 (4) , 618-624
Open AccessReduction of False-Positive Markings on Mammograms: a Retrospective Comparison Study Using an Artificial Intelligence-Based CAD
The aim was to determine whether an artificial intelligence (AI)-based, computer-aided detection (CAD) software can be used to reduce false positive per image (FPPI) on mammograms as compared to an FDA-approved conventional CAD. A retrospective study was performed on a set of 250 full-field digital mammograms between January 1, 2013, and March 31, 2013, and the number of marked regions of interest of two different systems was compared for sensitivity and specificity in cancer detection. The count of false-positive marks per image (FPPI) of the two systems was also evaluated as well as the number of cases that were completely mark-free. All results showed statistically significant reductions in false marks with the use of AI-CAD vs CAD (confidence interval = 95%) with no reduction in sensitivity. There is an overall 69% reduction in FPPI using the AI-based CAD as compared to CAD, consisting of 83% reduction in FPPI for calcifications and 56% reduction for masses. Almost half (48%) of cases showed no AI-CAD markings while only 17% show no conventional CAD marks. There was a significant reduction in FPPI with AI-CAD as compared to CAD for both masses and calcifications at all tissue densities. A 69% decrease in FPPI could result in a 17% decrease in radiologist reading time per case based on prior literature of CAD reading times. Additionally, decreasing false-positive recalls in screening mammography has many direct social and economic benefits.
- 17 December 2018
- Published by Wiley in The Breast Journal
- Vol. 25 (1) , 153
Axillary web syndrome: What the radiologist needs to know
- 17 December 2018
- Published by Wiley in The Breast Journal
- Vol. 25 (1) , 153
Axillary web syndrome: What the radiologist needs to know
- Open Access
- 30 June 2018
- Published by ClinMed International Library in International Journal of Cancer and Clinical Research
- Vol. 5 (2)
What the Oncologist Needs to Know about Axillary Web Syndrome
A 60 yr female underwent bilateral skin sparing mastectomy with bilateral sentinel lymph node biopsies. Two months after her surgery, the patient began to notice increasing constant pain and stiffness in her shoulders bilaterally and difficulty reaching overhead
- 30 June 2018
- Published by ClinMed International Library in International Journal of Cancer and Clinical Research
- Vol. 5 (2)
Open AccessWhat the Oncologist Needs to Know about Axillary Web Syndrome
A 60 yr female underwent bilateral skin sparing mastectomy with bilateral sentinel lymph node biopsies. Two months after her surgery, the patient began to notice increasing constant pain and stiffness in her shoulders bilaterally and difficulty reaching overhead
- Open Access
- 30 June 2018
- Published by ClinMed International Library in International Journal of Cancer and Clinical Research
- Vol. 5 (2)
Axillary Web Syndrome: What the Radiologist Needs to Know
A 60 yr African American female was called back from her annual screening mammogram for an asymmetry in the upper outer quadrant of the left breast on the MLO view. Ultrasound revealed a 1.7 cm irregular hypoechoic mass with indistinct margins. Additionally multiple sub centimeter non-contiguous hypoechoic satellite masses extended towards the nipple. One axillary node showed focal cortical thickening.
- 30 June 2018
- Published by ClinMed International Library in International Journal of Cancer and Clinical Research
- Vol. 5 (2)
Open AccessAxillary Web Syndrome: What the Radiologist Needs to Know
A 60 yr African American female was called back from her annual screening mammogram for an asymmetry in the upper outer quadrant of the left breast on the MLO view. Ultrasound revealed a 1.7 cm irregular hypoechoic mass with indistinct margins. Additionally multiple sub centimeter non-contiguous hypoechoic satellite masses extended towards the nipple. One axillary node showed focal cortical thickening.